The bars show 95 percent confidence intervals. Table 1 Risk of Progression among 1384 Residents of Southeastern Minnesota in Whom Monoclonal Gammopathy of Undetermined Significance was Diagnosed ...

Progression-free survival was measured from ... to follow-up to the status of having died (hazard ratio, 0.68; P=0.02) (Table S4 in the Supplementary Appendix). Multivariable analyses of overall ...

Table 1 Prospective observational studies investigating emerging risk factors and markers for CKD progression * This Review focuses on possible risk factors and markers of CKD progression for ...

The epidemiological findings are presented in Table 4. In VHA, the incident MGUS was 690 cases in 2000 and increased to 4,827 in 2019 before the COVID-19 pandemic; the progression was 108 cases in ...

Table 4. Summary of Treatment-Related Adverse Events in All Treated Patients and 5-Year Survivors Two of the 16 5-year survivors were treated with nivolumab beyond disease progression. One of the two ...

This progression is associated with impaired health ... to preserving kidney function and delaying disease progression (Table 1 8,19,22). A series of smaller clinical trials have suggested that ...